Mr Gunderson-Briggs joined the Board of Harvey Norman Holdings Limited (ASX: HVN) in 2003 and has acted as the Chair of the Remuneration Committee since 2015 and Chair of the Audit & Risk Committee and Nomination Committee since 2020. Mr Gunderson-Briggs was an independent Non-Executive Director of Australian Pharmaceutical Industries Limited from 2014 to 2022 (acting as Chair of the Board from 2020), concluding at the time Wesfarmers Limited completed the takeover of Australian Pharmaceutical Industries Limited in March 2022.
Kenneth Gunderson-Briggs
Non-Executive Director / National Tyre & Wheel